{"document": {"publication": "Tag My News", "full_text": "drugs for rare cancers are allowed to hit the u.s. market based on low-quality clinical tests that raise concerns about both safety and efficacy, researchers said monday.", "title": "drugs for rare cancers approved after subpar tests", "line_count": 1, "filename": "23470", "publication_date": "06-06-2011 23:39:05", "lines_and_colors": [["drugs for rare cancers are allowed to hit the u.s. market based on low-quality clinical tests that raise concerns about both safety and efficacy, researchers said monday.", {}]]}}